Silver Bullet Therapeutics Announces Podcast Scheduled to Air on March 2, 2025

The Company Will Also be in Attendance at Upcoming AAOS Meeting

SAN JOSE, Calif., Feb. 27, 2025 /PRNewswire/ -- Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that they have been featured by Merge Medical in their Startup Podcast hosted by Jeffrey Cole, MD and Jeffrey Brown, DO. This podcast is scheduled to air on March 2, 2025, and will be available at https://youtu.be/iI1YQdY-SDEl or mergemedical.org.

This podcast episode will explore the innovative technologies and future directions of Silver Bullet Therapeutics, focusing on their groundbreaking antimicrobial solutions for orthopedic applications. Listeners can look forward to insights into the development and scientific principles behind the company's proprietary technologies.

The Company will also be in attendance at the upcoming American Academy of Orthopedic Surgery in San DiegoMarch 11-14, 2025 and can be found in Booth #1409. OrthoFuzIon™ Orthopedic System is a comprehensive antimicrobial coating technology. The first application is a bone screw product line for orthopedic procedures. In the EU, the OrthoFuzIon™ Bone Screws are now approved for commercialization and indicated for open reduction and internal fixation (ORIF) fracture surgeries.

Silver Bullet Therapeutics has built an extensive intellectual property portfolio that has allowed the company to develop and validate coating processes for a wide variety of metallic, polymer, and electronic medical devices.

About Silver Bullet Therapeutics
Silver Bullet Therapeutics, Inc., located in San Jose, CA, has developed and patented antimicrobial coatings to address surgical-site and hospital-acquired infections by preventing microbial colonization of implanted medical devices. The Company's first product, the OrthoFuzIon™ Bone Screw System, utilizes Silver Bullet Therapeutics proprietary blend of platinum and silver technology, called AntiBacterIon™, that allows for rapid ionization of silver and creation of an antimicrobial zone around a bone screw anywhere in the body. Silver Bullet Therapeutics has already developed and validated processes to allow coating of a wide range of devices including both metallic and polymer devices. OrthoFuzIon™ and AntiBacterIon™ are Trademarks of Silver Bullet Therapeutics, Inc. and is pending FDA clearance and not yet approved for sale in the United States.

View original content:https://www.prnewswire.com/news-releases/silver-bullet-therapeutics-announces-podcast-scheduled-to-air-on-march-2-2025-302387923.html

SOURCE Silver Bullet Therapeutics